首页> 外文期刊>Clinical medicine: journal of the Royal College of Physicians of London >Systematic review of the efficacy of statins for the treatment of Alzheimer's disease
【24h】

Systematic review of the efficacy of statins for the treatment of Alzheimer's disease

机译:系统综述他汀类药物治疗阿尔茨海默病的疗效

获取原文
获取原文并翻译 | 示例
           

摘要

Alzheimer's disease (AD) is the most common type of dementia. Recent studies have assessed the possibility of using statins as treatment for AD. However, their efficacy is not clear. In this study, we collected the most relevant information about the efficacy of statins for the treatment of AD. We conducted a systematic literature search using MEDLINE, EMBASE and The Cochrane Library. We included clinical trials, meta-analyses and systematic reviews that analysed the efficacy of statins in AD. We also extracted the characteristics and efficacy results of the studies selected. Of the 304 articles identified, 13 complied with the inclusion criteria. The scientific quality of studies was high and their results indicated that there were no significant differences in the main efficacy variables between statins and placebo treatment for AD. Therefore, according to the available scientific evidence, statins have not shown an improvement in cognition and do not appear to offer significant benefits to patients with AD.
机译:阿尔茨海默病(AD)是最常见的痴呆类型。最近的研究已经评估了使用他汀类药物作为广告治疗的可能性。然而,他们的疗效尚不清楚。在这项研究中,我们收集了有关他汀类药物治疗AD的疗效的最相关信息。我们使用Medline,Embase和Cochrane图书馆进行了系统的文献搜索。我们包括临床试验,荟萃分析和系统评论,分析了他汀类药物在广告中的疗效。我们还提取了所选研究的特征和功效结果。在确定的304篇文章中,13符合纳入标准。科学的研究质量很高,结果表明,他汀类药物与安慰剂治疗之间的主要疗效变量没有显着差异。因此,根据可用的科学证据,他汀类药物没有显示出认知的改善,并且似乎对AD患者似乎没有具有显着的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号